# Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression

> **NCT05779553** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 90 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits

## Key facts

- **NCT ID:** NCT05779553
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05779553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05779553, "Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05779553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*